Author:
Chijioke-Nwauche Ifeyinwa N.,Awanye Amaka M.
Publisher
Springer Nature Switzerland
Reference52 articles.
1. Barnes KI, White NJ. Population biology and antimalarial resistance: the transmission of antimalarial drug resistance in Plasmodium falciparum. Acta Trop. 2005;94:230–40.
2. Bates I, Fenton C, Gruber J, Lalloo D, Lara AM, Squire SB, Theobald S, Thomson R, Tolhurst R. Vulnerability to malaria, tuberculosis, and HIV/AIDS infection and disease. Part II: determinants operating at environmental and institutional level. Lancet Infect Dis. 2004;4:368–75.
3. Birku Y, Mekonnen E, Bjorkman A, Wolday D. Delayed clearance of Plasmodium falciparum in patients with human immunodeficiency virus co-infection treated with artemisinin. Ethiop Med J. 2002;40(Suppl 1):17–26.
4. Björkman A, Bhattarai A. Public health impact of drug resistant Plasmodium falciparum malaria. Acta Trop. 2005;94(3):163–9.
5. Bloland PB. Drug resistance in malaria. WHO/CDS/CSR/DRS/2001.4, 2001.